Change location

You are about to change the origin location from where you are visiting

*The location of origin is defined in your browser settings and may not be identical with your citizenship and/or your domicile.

Choose Language
Deutsch Die Seite ist nicht verfügbar
Englische Startseite
Français Page indisponible
Page d'accueil en Francais
Italiano Pagina non disponibile
Home page di Italia

Asian Investment Conference 2021

Jim Mellon

Director, Agronomics

Luke Sedler

Jim Mellon is Director of Agronomics. Mr. Mellon is also an entrepreneur, investor, and philanthropist. Through his private investment company, Burnbrae Group, he has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies.

Mr. Mellon’s investment philosophy is underpinned by careful analysis of new industries or major shifts in markets. This includes the global financial crisis of 2008-2009, as presented in the first book Mr. Mellon co-authored, entitled, Wake Up!. The same philosophy is also evident in Mr. Mellon’s subsequent book, Juvenescence, which marked the beginning of a rush of capital into the nascent field of ageing research and also led to the formation of the company Juvenescence with his partners. Juvenescence is a leading biopharma company in the commercialization of therapies to slow, stop and reverse aging. More recently, Mr. Mellon authored the book, Moo’s Law, which focuses on investment opportunities in the New Agrarian Revolution and fields of cellular agriculture. Mr. Mellon co-founded Agronomics to invest in a portfolio of leading companies in this sector.

Mr. Mellon sits on the Board of Trustees of the Buck Institute for Research on Aging, and of the American Federation for Aging Research (AFAR). He is also a Trustee of Biogerontology Research Foundation and is an Honorary Fellow of Oriel College at the University of Oxford, where he has established the Mellon Centre for Longevity. Mr. Mellon also sits on the Advisory Board of the Milken Institute’s Centre for the Future of Aging.